Adenoviral vector-based SARS-CoV-2 vaccine (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenoviral vector-based SARS-CoV-2 vaccine (unspecified), covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector [NA]